[{"from": "human", "value": "Could you provide a description of this molecule? [C][O][C][=C][C][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][C][C][=C][Branch2][Ring1][=Branch1][C][C][N][Ring1][=Branch1][C][=Branch1][C][=O][O][C][=C][C][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][Cl][C][=C][Branch1][Branch1][N][Ring2][Ring1][C][C][=C][C][=Branch1][Ring2][=C][Ring1][#Branch1][Cl]"}, {"from": "gpt", "value": "The molecule is a novel, orally administered small-molecule designed to inhibit the production of vascular endothelial growth factor (VEGF) in tumors. Overexpression of VEGF plays a key role in multiple diseases including cancer and macular degeneration. PTC299 was discovered through PTC's GEMS technology by targeting the post-transcriptional processes that regulate VEGF formation, and is currently being developed for the treatment of cancer."}]